8-K
filed August 21, 2024, 7:59 PM ET
CIK 0001835416
M&A
confidence high
sentiment neutral
materiality 0.65
Moringa Acquisition Corp completes de-SPAC merger with Silexion; begins trading as SLXN
Moringa Acquisition Corp
- Business combination closed Aug. 15, 2024; combined company renamed Silexion Therapeutics Corp, trading on Nasdaq under SLXN and SLXNW starting Aug. 16, 2024.
- Redemptions: 427,297 Moringa Class A shares redeemed; 87,722 public shares remained and converted into New Pubco ordinary shares.
- Post-combination: 9,768,396 ordinary shares and 5,940,000 warrants outstanding; Greenstar, L.P. purchased 200,000 shares at $10 each ($2M) in a private placement.
- Directors Ruth Alon, Michael Basch, Eric Brachfeld, Craig Marshak resigned; CEO Ilan Levin and CFO Gil Maman left; Ilan Hadar appointed as director.
- Moringa securities delisted from Nasdaq; public shareholders who did not redeem received shares of the combined company.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Eric Brachfeld departed as Director at Moringa Acquisition Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Ilan Levin departed as Chief Executive Officer at Moringa Acquisition Corp.
- Action
- ceased
- Role
- Chief Executive Officer
Exact text from the filing
Ilan Levin and Gil Maman ceased to be the Chief Executive Officer and Chief Financial Officer, respectively, of Moringa
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Michael Basch departed as Director at Moringa Acquisition Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Ilan Hadar was appointed as Director at Moringa Acquisition Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
Ilan Hadar was appointed a director of Moringa immediately following the consummation of the Business Combination
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Craig Marshak departed as Director at Moringa Acquisition Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Gil Maman departed as Chief Financial Officer at Moringa Acquisition Corp.
- Action
- ceased
- Role
- Chief Financial Officer
Exact text from the filing
Ilan Levin and Gil Maman ceased to be the Chief Executive Officer and Chief Financial Officer, respectively, of Moringa
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Ruth Alon departed as Director at Moringa Acquisition Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
each of Ruth Alon, Michael Basch, Eric Brachfeld and Craig Marshak ceased to be a director of Moringa
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.